USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$24.87B
Market Cap
36.12
P/E Ratio
6.99
EPS
$268.60
52 Week High
$198.98
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.4B |
| Total Revenue | $5.5B |
| Cost Of Revenue | $3.1B |
| Costof Goods And Services Sold | $3.1B |
| Operating Income | $867M |
| Selling General And Administrative | $1.3B |
| Research And Development | $108M |
| Operating Expenses | $1.5B |
| Investment Income Net | - |
| Net Interest Income | -$78M |
| Interest Income | $8.4M |
| Interest Expense | $86M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $476M |
| Income Before Tax | $796M |
| Income Tax Expense | $185M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $612M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $882M |
| Ebitda | $1.4B |
| Net Income | $615M |
| Field | Value (USD) |
|---|---|
| Total Assets | $10B |
| Total Current Assets | $2B |
| Cash And Cash Equivalents At Carrying Value | $172M |
| Cash And Short Term Investments | $172M |
| Inventory | $581M |
| Current Net Receivables | $1B |
| Total Non Current Assets | $8.1B |
| Property Plant Equipment | $2.1B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $1.9B |
| Intangible Assets Excluding Goodwill | $1.9B |
| Goodwill | $4.1B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $204M |
| Other Non Current Assets | - |
| Total Liabilities | $3.5B |
| Total Current Liabilities | $1B |
| Current Accounts Payable | $281M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $159M |
| Total Non Current Liabilities | $2.5B |
| Capital Lease Obligations | $159M |
| Long Term Debt | $1.9B |
| Current Long Term Debt | $125M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $2.2B |
| Other Current Liabilities | $525M |
| Other Non Current Liabilities | $13M |
| Total Shareholder Equity | $6.6B |
| Treasury Stock | - |
| Retained Earnings | $2.5B |
| Common Stock | $4.4B |
| Common Stock Shares Outstanding | $99M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.4B |
| Total Revenue | $5.5B |
| Cost Of Revenue | $3.1B |
| Costof Goods And Services Sold | $3.1B |
| Operating Income | $867M |
| Selling General And Administrative | $1.3B |
| Research And Development | $108M |
| Operating Expenses | $1.5B |
| Investment Income Net | - |
| Net Interest Income | -$78M |
| Interest Income | $8.4M |
| Interest Expense | $86M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $476M |
| Income Before Tax | $796M |
| Income Tax Expense | $185M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $612M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $882M |
| Ebitda | $1.4B |
| Net Income | $615M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
STERIS plc is a premier global provider of healthcare and surgical solutions, dedicated to enhancing operational efficiency and patient safety through advanced sterilization technologies. Headquartered in Ireland, the company offers a comprehensive suite of innovative products and services designed to prevent infection and improve healthcare outcomes across diverse medical environments. With a strong commitment to quality and innovation, STERIS is well-positioned as a trusted partner in the dynamic global healthcare market, serving a broad array of clinical applications and navigating the complexities of evolving healthcare demands.